Gastroenterology Unit, Azienda Ospedaliero-Universitaria Maggiore della Carità, Corso Mazzini, 18, 28100 Novara, Italy.
World J Gastroenterol. 2010 Feb 7;16(5):596-602. doi: 10.3748/wjg.v16.i5.596.
To investigate the usefulness of mild iron depletion and the factors predictive for histological improvement following phlebotomy in Caucasians with chronic hepatitis C (CHC).
We investigated 28 CHC Caucasians with persistently elevated serum aminotransferase levels and non responders to, or unsuitable for, antiviral therapy who underwent mild iron depletion (ferritin < or = 70 ng/mL) by long-term phlebotomy. Histological improvement, as defined by at least one point reduction in the staging score or, in case of unchanged stage, as at least two points reduction in the grading score (Knodell), was evaluated in two subsequent liver biopsies (before and at the end of phlebotomy, 48 +/- 16 mo apart).
Phlebotomy showed an excellent safety profile. Histological improvement occurred in 12/28 phlebotomized patients. Only males responded to phlebotomy. At univariate logistic analysis alcohol intake (P = 0.034), high histological grading (P = 0.01) and high hepatic iron concentration (HIC) (P = 0.04) before treatment were associated with histological improvement. Multivariate logistic analysis showed that in males high HIC was the only predictor of histological improvement following phlebotomy (OR = 1.41, 95% CI: 1.03-1.94, P = 0.031). Accordingly, 12 out of 17 (70%) patients with HIC > or = 20 micromol/g showed histological improvements at the second biopsy.
Male CHC Caucasian non-responders to antiviral therapy with low-grade iron overload can benefit from mild iron depletion by long-term phlebotomy.
研究轻度铁耗竭在白人慢性丙型肝炎(CHC)患者经放血治疗后组织学改善的作用及预测因素。
我们研究了 28 例白人慢性丙型肝炎患者,这些患者血清转氨酶持续升高,且对抗病毒治疗无反应或不适合抗病毒治疗,他们接受了长期放血治疗以实现轻度铁耗竭(铁蛋白<或=70ng/ml)。通过两次连续的肝活检(在放血治疗前和结束时进行,间隔 48 +/- 16 个月)评估组织学改善情况,定义为分期评分至少降低 1 分,或在分期不变的情况下,分级评分至少降低 2 分(Knodell)。
放血治疗具有良好的安全性。28 例放血治疗的患者中有 12 例发生了组织学改善。只有男性对放血治疗有反应。单因素逻辑分析显示,酒精摄入(P=0.034)、高组织学分级(P=0.01)和治疗前高肝铁浓度(HIC)(P=0.04)与组织学改善相关。多因素逻辑分析显示,在男性中,高 HIC 是放血治疗后组织学改善的唯一预测因素(OR=1.41,95%CI:1.03-1.94,P=0.031)。因此,在 HIC>或=20 微米ol/g 的 17 例患者中有 12 例(70%)在第二次肝活检时出现了组织学改善。
低级别铁过载、对抗病毒治疗无反应的白人慢性丙型肝炎男性患者可以从长期放血治疗轻度铁耗竭中获益。